Biomerica (BMRA) Net Equity Issued and Repurchased (2018 - 2026)

Biomerica (BMRA) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $63000.0 in Q1 2026.

• For the quarter ending Q1 2026, Net Equity Issued and Repurchased fell 96.4% year-over-year to $63000.0; the trailing twelve-month figure through Feb 2026 stood at $1.5 million (down 21.36% YoY), and the FY2025 full-year result was $2.1 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased fell to $63000.0 in Q1 2026, from $493000.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $1.8 million in Q3 2022 to a low of -$53000.0 in Q2 2023.
• A 4-year average of $584126.6 and a median of $309500.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
• Across the five-year window, Net Equity Issued and Repurchased soared 116.02% in 2022 and slumped 20024.81% in 2023, its largest moves.
• Tracing BMRA's Net Equity Issued and Repurchased over 4 years: stood at $126000.0 in 2022, then sank by 142.06% to -$53000.0 in 2023, then soared by 1030.19% to $493000.0 in 2025, then tumbled by 87.22% to $63000.0 in 2026.
• Business Quant data shows BMRA's Net Equity Issued and Repurchased at $63000.0 in Q1 2026, $493000.0 in Q4 2025, and $939000.0 in Q3 2025.